These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30861162)

  • 1. Initial experience in synthesis of (2S,4R)-4-[
    Zhang Y; Zhang L; Yang J; Wu Z; Ploessl K; Zha Z; Liu F; Xu X; Zhu H; Yang Z; Zhu L; Kung HF
    J Labelled Comp Radiopharm; 2019 May; 62(5):209-214. PubMed ID: 30861162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated synthesis of [(18)F](2S,4R)-4-fluoroglutamine on a GE TRACERlab™ FX-N Pro module.
    Zhang X; Basuli F; Shi ZD; Xu B; Blackman B; Choyke PL; Swenson RE
    Appl Radiat Isot; 2016 Jun; 112():110-4. PubMed ID: 27019029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alanine and glycine conjugates of (2S,4R)-4-[
    Zha Z; Ploessl K; Lieberman BP; Wang L; Kung HF
    Nucl Med Biol; 2018 May; 60():19-28. PubMed ID: 29525446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
    Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
    Front Immunol; 2022; 13():821423. PubMed ID: 35145523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Imaging of
    Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
    Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.
    Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Zhu L; Li N; Kung HF; Yang Z
    Clin Nucl Med; 2018 Nov; 43(11):e392-e399. PubMed ID: 30179907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [
    Baguet T; Verhoeven J; Pauwelyn G; Hu J; Lambe P; De Lombaerde S; Piron S; Donche S; Descamps B; Goethals I; Vanhove C; De Vos F; Beyzavi MH
    Nucl Med Biol; 2020; 86-87():20-29. PubMed ID: 32447069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate.
    Cooper AJ; Krasnikov BF; Pinto JT; Kung HF; Li J; Ploessl K
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):108-20. PubMed ID: 22613816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of
    Dunphy MPS; Harding JJ; Venneti S; Zhang H; Burnazi EM; Bromberg J; Omuro AM; Hsieh JJ; Mellinghoff IK; Staton K; Pressl C; Beattie BJ; Zanzonico PB; Gerecitano JF; Kelsen DP; Weber W; Lyashchenko SK; Kung HF; Lewis JS
    Radiology; 2018 May; 287(2):667-675. PubMed ID: 29388903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side Chain Optimization Remarkably Enhances the in Vivo Stability of
    Chen J; Li C; Hong H; Liu H; Wang C; Xu M; Han Y; Liu Z
    Mol Pharm; 2019 Dec; 16(12):5035-5041. PubMed ID: 31670970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
    Lieberman BP; Ploessl K; Wang L; Qu W; Zha Z; Wise DR; Chodosh LA; Belka G; Thompson CB; Kung HF
    J Nucl Med; 2011 Dec; 52(12):1947-55. PubMed ID: 22095958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[
    Pollard AC; Paolillo V; Radaram B; Qureshy S; Li L; Maity T; Wang L; Uddin MN; Wood CG; Karam JA; Pagel MD; Piwnica-Worms D; Millward SW; Fowlkes NW; Norton W; Engel BJ; Pisaneschi F; Zacharias NM
    Mol Imaging Biol; 2022 Dec; 24(6):959-972. PubMed ID: 35732988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (2S,4R)-4-[
    Zhu H; Liu F; Zhang Y; Yang J; Xu X; Guo X; Liu T; Li N; Zhu L; Kung HF; Yang Z
    Mol Imaging Biol; 2019 Oct; 21(5):945-953. PubMed ID: 30793240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorination at the 4 position alters the substrate behavior of L-glutamine and L-glutamate: Implications for positron emission tomography of neoplasias.
    Jeitner TM; Kristoferson E; Azcona JA; Pinto JT; Stalnecker C; Erickson JW; Kung HF; Li J; Ploessl K; Cooper AJL
    J Fluor Chem; 2016 Dec; 192(A):58-67. PubMed ID: 28546645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (2S, 4R)-4-[
    Miner MW; Liljenbäck H; Virta J; Merisaari J; Oikonen V; Westermarck J; Li XG; Roivainen A
    Mol Imaging Biol; 2020 Aug; 22(4):969-978. PubMed ID: 31993927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agent.
    Wu Z; Zha Z; Li G; Lieberman BP; Choi SR; Ploessl K; Kung HF
    Mol Pharm; 2014 Nov; 11(11):3852-66. PubMed ID: 25095908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic Assessment of
    Grkovski M; Goel R; Krebs S; Staton KD; Harding JJ; Mellinghoff IK; Humm JL; Dunphy MPS
    J Nucl Med; 2020 Mar; 61(3):357-366. PubMed ID: 31601700
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic Imaging of Glutamine in Cancer.
    Zhu L; Ploessl K; Zhou R; Mankoff D; Kung HF
    J Nucl Med; 2017 Apr; 58(4):533-537. PubMed ID: 28232608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents.
    Ploessl K; Wang L; Lieberman BP; Qu W; Kung HF
    J Nucl Med; 2012 Oct; 53(10):1616-24. PubMed ID: 22935578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Seo Y; Craig MC; Murphy ST; Feng J; Chen X; Yuneva M
    Mol Imaging; 2022; 2022():5185951. PubMed ID: 35967756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.